Dr. Zeng is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
204 raymond road
Marlboro, MA 01752Phone+1 508-281-1674
Education & Training
Hartford HospitalResidency, Pathology-Anatomic and Clinical, 2005
Yale UniversityPhD, Post doctoral research, 2000 - 2003
Lehigh UniversityPhD, Pharmaceutical Chemistry, 1995 - 2000
Xi'an Jiaotong Medical UniversityClass of 1993
Clinical Trials
- Sintilimab Injection Combined With Inlyta in Fumarate Hydratase- Deficient Renal Cell Carcinoma Start of enrollment: 2021 Jul 01
Publications & Presentations
PubMed
- 49 citationsmTORC1 signaling suppresses Wnt/β-catenin signaling through DVL-dependent regulation of Wnt receptor FZD levelHao Zeng, Bo Lu, Raffaella Zamponi, Zinger Yang, Kristie Wetzel
Proceedings of the National Academy of Sciences of the United States of America. 2018-10-30
Journal Articles
- Adjuvants for Coronavirus VaccinesHao Zeng, MD, Frontiers in Immunology
- mTORC1 Signaling Suppresses Wnt/Β-catenin Signaling Through DVL-Dependent Regulation of Wnt Receptor FZD LevelHao Zeng, MD, Proceedings of the National Academy of Sciences
Other Languages
- Chinese (Mandarin)
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
